Le SIDA en Afrique subsaharienne (serveur d'exploration) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Tenofovir »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Temperature < Tenofovir < Terminology as Topic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000C34 (2010) Niel Malan [Afrique du Sud] ; Jun Su ; Marco Mancini ; Rong Yang ; Victoria Wirtz ; Judith Absalon ; Donnie McgrathGastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
000E05 (2010) Jon CohenHIV/AIDS. At last, vaginal gel scores victory against HIV.
000E06 (2010) Quarraisha Abdool Karim [Afrique du Sud] ; Salim S. Abdool Karim ; Janet A. Frohlich ; Anneke C. Grobler ; Cheryl Baxter ; Leila E. Mansoor ; Ayesha B M. Kharsany ; Sengeziwe Sibeko ; Koleka P. Mlisana ; Zaheen Omar ; Tanuja N. Gengiah ; Silvia Maarschalk ; Natasha Arulappan ; Mukelisiwe Mlotshwa ; Lynn Morris ; Douglas TaylorEffectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
000E73 (2010) Dara MohammadiTrial results finally show potential for microbicidal HIV gel.
000E88 (2010) Elise Arrivé ; Marie-Laure Chaix ; Eric Nerrienet ; Stéphane Blanche ; Christine Rouzioux ; Divine Avit ; Leang Sim Kruy ; James Mcintyre ; Leakhena Say ; Glenda Gray ; Didier K. Ekouévi ; François DabisMaternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance.
000F19 (2010) Pierre De Beaudrap [France] ; Mouhamadou Baila Diallo ; Roland Landman ; Ndeye Fatou Guèye ; Ibrahima Ndiaye ; Assane Diouf ; Coumba Toure Kane ; Jean-Francois Etard ; Pierre-Marie Girard ; Papa Salif Sow ; Eric DelaporteChanges in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
001250 (????) Willard Cates ; Angela D M. KashubaThe North Carolina contribution to the CAPRISA 004 study: the Global Health Initiative in action.
001904 (2013) David C. Sokal [États-Unis] ; Quarraisha Abdool Karim ; Sengeziwe Sibeko ; Nonhlanhla Yende-Zuma ; Leila E. Mansoor ; Cheryl Baxter ; Anneke Grobler ; Janet Frolich ; Ayesha Bm Kharsany ; Nomsa Miya ; Koleka Mlisana ; Silvia Maarshalk ; Salim S Abdool KarimSafety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial.
001991 (2013) Alexandra M. Minnis [États-Unis] ; Sharavi Gandham ; Barbra A. Richardson ; Vijayanand Guddera ; Beatrice A. Chen ; Robert Salata ; Clemensia Nakabiito ; Craig Hoesley ; Jessica Justman ; Lydia Soto-Torres ; Karen Patterson ; Kailazarid Gomez ; Craig W. HendrixAdherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.
001D52 (2013) Vivek Naranbhai [Afrique du Sud] ; Natasha Samsunder ; Netanya G. Sandler ; Annalys Roque ; Quarraisha Abdool Karim ; Thumbi Ndung U ; William H. Carr ; Marcus Altfeld ; Daniel C. Douek ; Salim S. Abdool KarimNeither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004.
001E41 (2013) James N. Kiage [États-Unis] ; Douglas C. Heimburger ; Christopher K. Nyirenda ; Melissa F. Wellons ; Shashwatee Bagchi ; Benjamin H. Chi ; John R. Koethe ; Donna K. Arnett ; Edmond K. KabagambeCardiometabolic risk factors among HIV patients on antiretroviral therapy.
001F02 (2013) Eric Ouattara [France] ; Christine Danel ; Raoul Moh ; Delphine Gabillard ; Gilles Peytavin ; Romuald Konan ; Jérome Le Carrou ; Franck Bohoussou ; Serge P. Eholie ; Xavier AnglaretEarly upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.
002038 (2013) Salim S Abdool Karim [Afrique du Sud]HIV pre-exposure prophylaxis in injecting drug users.
002221 (2013) David A M C. Van De Vijver [Pays-Bas] ; Brooke E. Nichols ; Ume L. Abbas ; Charles A B. Boucher ; Valentina Cambiano ; Jeffrey W. Eaton ; Robert Glaubius ; Katrina Lythgoe ; John Mellors ; Andrew Phillips ; Kim C. Sigaloff ; Timothy B. HallettPreexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.
002291 (2013) Denis R. Chopera [Canada] ; Jaclyn K. Mann ; Philip Mwimanzi ; Saleha Omarjee ; Xiaomei T. Kuang ; Nonkululeko Ndabambi ; Sarah Goodier ; Eric Martin ; Vivek Naranbhai ; Salim Abdool Karim ; Quarraisha Abdool Karim ; Zabrina L. Brumme ; Thumbi Ndung'U ; Carolyn Williamson ; Mark A. BrockmanNo evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.
002382 (2013) Landon Myer [Afrique du Sud] ; Monika Kamkuemah ; Richard Kaplan ; Linda-Gail BekkerLow prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
002522 (2013) Alana T. Brennan [États-Unis] ; Mhairi Maskew ; Prudence Ive ; Kate Shearer ; Lawrence Long ; Ian Sanne ; Matthew P. FoxIncreases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa.
002626 (2014) Andrew D. Redd [États-Unis] ; Caroline E. Mullis ; Sarah K. Wendel ; Daniel Sheward ; Craig Martens ; Daniel Bruno ; Lise Werner ; Nigel J. Garrett ; Quarraisha Abdool Karim ; Carolyn Williamson ; Stephen F. Porcella ; Thomas C. Quinn ; Salim S. Abdool KarimLimited HIV-1 superinfection in seroconverters from the CAPRISA 004 Microbicide Trial.
003B06 (2017) Eliza M. Govender [Afrique du Sud] ; Leila E. Mansoor [Afrique du Sud] ; Quarraisha Abdool Karim [Afrique du Sud]Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
003B15 (2017) Mark A. Boyd [Australie] ; Janaki Amin [Australie] ; Patrick W G. Mallon [Irlande (pays)] ; Nagalingeswaran Kumarasamy [Inde] ; Johan Lombaard [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Ploenchan Chetchotisakd [Thaïlande] ; Praphan Phanuphak [Thaïlande] ; Lerato Mohapi [Afrique du Sud] ; Iskandar Azwa [Malaisie] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; Jennifer Hoy [Australie] ; Cecilia L. Moore [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie]Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
003B77 (2017) John Gregson [Royaume-Uni] ; Pontiano Kaleebu [Ouganda] ; Vincent C. Marconi [États-Unis] ; Cloete Van Vuuren [Afrique du Sud] ; Nicaise Ndembi [Nigeria] ; Raph L. Hamers [Pays-Bas] ; Phyllis Kanki [États-Unis] ; Christopher J. Hoffmann [États-Unis] ; Shahin Lockman [États-Unis] ; Deenan Pillay [Afrique du Sud] ; Tulio De Oliveira [Afrique du Sud] ; Nathan Clumeck [Belgique] ; Gillian Hunt [Afrique du Sud] ; Bernhard Kerschberger [Swaziland] ; Robert W. Shafer [États-Unis] ; Chunfu Yang [États-Unis] ; Elliot Raizes [États-Unis] ; Rami Kantor [États-Unis] ; Ravindra K. Gupta [Afrique du Sud]Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Tenofovir" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Tenofovir" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Tenofovir
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024